secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pasithea Therapeutics Corp. (KTTA)
CIK:        0001841330
Form:       8-K
Filed at:   2026-01-28T23:59:59+00:00
Accession:  0001213900-26-008828
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pasithea stockholders approve 5x increase in authorized common stock and 7x expansion of incentive plan
--------------------------------------------------------------------------------

- Authorized common stock increased from 100M to 500M shares via certificate amendment filed Jan 28, 2026.
- 2023 Stock Incentive Plan share reserve raised from 2,014,221 to 14,000,000 shares (increase of 11,985,779).
- Proposal 1 (share increase) passed with 16,066,757 votes for vs 647,972 against; Proposal 2 passed with 8,168,126 for vs 4,550,855 against.
- Board adopted plan amendment on Dec 18, 2025; stockholder approval obtained at Jan 28, 2026 special meeting.
- Expanded authorized shares and equity plan provide flexibility for future capital raising and employee incentives.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841330/000121390026008828/0001213900-26-008828-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841330/000121390026008828/ea0274244-8k_pasithea.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-008828

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer